Canada - English - Health Canada

sandoz canada incorporated - fluoxetine (fluoxetine hydrochloride) - capsule - 10mg - fluoxetine (fluoxetine hydrochloride) 10mg - selective-serotonin reuptake inhibitors

Canada - English - Health Canada

sandoz canada incorporated - fluoxetine (fluoxetine hydrochloride) - capsule - 20mg - fluoxetine (fluoxetine hydrochloride) 20mg - selective-serotonin reuptake inhibitors

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

rx farma - fluoxetine hydrochloride - oral capsule - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

noumed life sciences ltd - fluoxetine hydrochloride - oral capsule - 20mg

Canada - English - Health Canada

apotex inc - fluoxetine (fluoxetine hydrochloride) - capsule - 20mg - fluoxetine (fluoxetine hydrochloride) 20mg - selective-serotonin reuptake inhibitors

Canada - English - Health Canada

apotex inc - fluoxetine (fluoxetine hydrochloride) - capsule - 10mg - fluoxetine (fluoxetine hydrochloride) 10mg - selective-serotonin reuptake inhibitors

Canada - English - Health Canada

apotex inc - fluoxetine (fluoxetine hydrochloride) - capsule - 10mg - fluoxetine (fluoxetine hydrochloride) 10mg - selective-serotonin reuptake inhibitors

Canada - English - Health Canada

apotex inc - fluoxetine (fluoxetine hydrochloride) - capsule - 20mg - fluoxetine (fluoxetine hydrochloride) 20mg - selective-serotonin reuptake inhibitors

Canada - English - Health Canada

pro doc limitee - fluoxetine (fluoxetine hydrochloride) - capsule - 10mg - fluoxetine (fluoxetine hydrochloride) 10mg - selective-serotonin reuptake inhibitors

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine 10 mg - fluoxetine is indicated for the acute and maintenance treatment of major depressive disorder in adult patients and in pediatric patients aged 8 to 18 years [see clinical studies (14.1) ]. the usefulness of the drug in adult and pediatric patients receiving fluoxetine for extended periods should periodically be re-evaluated [see dosage and administration (2.1) ]. fluoxetine is indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with obsessive compulsive disorder (ocd) [see clinical studies (14.2) ]. the effectiveness of fluoxetine in long-term use, i.e., for more than 13 weeks, has not been systematically evaluated in placebo-controlled trials. therefore, the physician who elects to use fluoxetine for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient [see dosage and administration (2.2) ]. fluoxetine is indicated for the acute and maintenance treatment of bin